
Sign up to save your podcasts
Or


In this episode, Barbara Pruitt sits down with pediatric hematologist Dr. Rachael Grace to take the mystery out of clinical trials for ITP. Dr. Grace explains what clinical trials are, how they differ from standard treatment, and why both research studies and clinical trials play a crucial role in improving care. They discuss when a clinical trial might be a good option; common concerns patients have, what participation actually looks like, and how research has already shaped major advancements in ITP treatment. Whether you’re curious about future options, want to help move ITP research forward, or simply want to better understand what your hematologist might be recommending, this episode offers clarity, reassurance, and insight straight from an expert.
By PDSAIn this episode, Barbara Pruitt sits down with pediatric hematologist Dr. Rachael Grace to take the mystery out of clinical trials for ITP. Dr. Grace explains what clinical trials are, how they differ from standard treatment, and why both research studies and clinical trials play a crucial role in improving care. They discuss when a clinical trial might be a good option; common concerns patients have, what participation actually looks like, and how research has already shaped major advancements in ITP treatment. Whether you’re curious about future options, want to help move ITP research forward, or simply want to better understand what your hematologist might be recommending, this episode offers clarity, reassurance, and insight straight from an expert.